Company Filing History:
Years Active: 2013
Title: Inventor Peter David: Pioneering Solutions for Gestational Malaria
Introduction
Peter David is an accomplished inventor based in Paris, France, known for his significant contributions to the field of medical science. With one registered patent to his name, David has focused his research on addressing the pressing issue of gestational malaria, utilizing innovative polynucleotide and polypeptide technologies.
Latest Patents
David's notable patent revolves around "Polynucleotides and polypeptides involved in gestational malaria, and biological applications." This groundbreaking disclosure introduces novel antigens associated with gestational malaria. His work emphasizes the development of polynucleotide and polypeptide sequences, conjugates, and cloning vectors aimed at producing immunogenic compositions and vaccines. Additionally, it encompasses antibodies that aim to treat gestational malaria. The patent also outlines various diagnostic methods and kits designed for effective utilization in medical practices.
Career Highlights
Throughout his career, Peter David has collaborated with esteemed institutions such as the Institut de Recherche pour le Développement (IRD) and the Institut Pasteur. His experience at these prominent research organizations has enabled him to refine his innovative approaches and contribute to impactful scientific advancements.
Collaborations
David has had the opportunity to work alongside distinguished colleagues, including Philippe Deloron and Nicaise George Tuikue Ndam. These collaborations have allowed for a dynamic exchange of ideas and expertise, further enhancing the development of solutions to combat gestational malaria.
Conclusion
Peter David's work exemplifies the essence of innovation in the healthcare sector. By creating novel solutions for gestational malaria, he has paved the way for future research and advancements in this critical area. His insights and inventions have the potential to significantly improve the lives of those affected by this condition, highlighting the importance of continued research and collaboration in combating global health challenges.